Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
Holding BCYC?
Track your performance easily

Bicycle Therapeutics (BCYC) Financial Statements

343 Followers

Bicycle Therapeutics Financial Overview

Bicycle Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.811; its P/E ratio is -6.30; Bicycle Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 9.36M$ 19.53M$ 5.33M$ 5.35M$ 11.40M
Gross Profit$ 9.36M$ 19.53M$ 5.33M$ 5.35M$ 11.40M
EBIT$ -39.70M$ -26.09M$ -47.96M$ -46.81M$ -42.30M
EBITDA$ -38.06M$ -24.43M$ -46.30M$ -45.12M$ -40.65M
Net Income Common Stockholders$ -38.97M$ -26.60M$ -49.10M$ -49.93M$ -42.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 961.40M$ 457.00M$ 526.40M$ 572.10M$ 340.40M
Total Assets$ 1.06B$ 547.14M$ 595.34M$ 638.68M$ 454.14M
Total Debt$ 37.64M$ 38.85M$ 40.08M$ 41.03M$ 42.39M
Net Debt$ -923.76M$ -418.15M$ -486.32M$ -531.07M$ -298.01M
Total Liabilities$ 183.54M$ 191.09M$ 224.41M$ 222.66M$ 234.07M
Stockholders Equity$ 873.85M$ 356.05M$ 370.93M$ 416.02M$ 220.06M
Cash Flow-
Free Cash Flow$ -45.05M$ -70.88M$ -47.34M$ -1.53M$ 33.82M
Operating Cash Flow$ -44.63M$ -70.87M$ -47.29M$ -1.02M$ 34.10M
Investing Cash Flow$ -420.00K$ -12.00K$ -51.00K$ -502.00K$ -277.00K
Financing Cash Flow$ 549.61M$ 1.87M$ 386.00K$ 234.63M$ 12.29M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Bicycle Therapeutics Debt to Assets

Bicycle Therapeutics Cash Flow

Bicycle Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis